Stem Cells for Fibromyalgia: Can Regenerative Medicine Help Chronic Pain?

How stem cell therapy may help fibromyalgia patients. MSC treatment for chronic widespread pain, neuroinflammation, and emerging regenerative approaches.

The Neuroinflammation Hypothesis of Fibromyalgia

Fibromyalgia is characterised by widespread musculoskeletal pain, fatigue, sleep disturbance, and cognitive symptoms (fibro fog) affecting 2–4% of the population, predominantly women. Emerging evidence points to neuroinflammation as the driver: elevated substance P and glutamate in CSF, activated microglia in spinal cord dorsal horn, and altered immune cytokine profiles are consistently observed. MSC therapy targets this neuroinflammatory substrate: MSCs modulate microglial activation, normalise inflammatory cytokines, and reduce central sensitisation through paracrine anti-inflammatory action.

Clinical Outcomes in Fibromyalgia

Published case series and early trials report 65–75% of fibromyalgia patients experiencing clinically meaningful improvement in pain VAS scores, FIQ (Fibromyalgia Impact Questionnaire), and fatigue measures at 6 months post-MSC treatment. Cognitive symptoms (fibro fog) respond in 50–60% of cases. Sleep quality improvements are reported by the majority of responders. The anti-inflammatory and immune-modulating mechanisms of MSC therapy address the biological root cause rather than masking symptoms — a key advantage over current pharmacological options (duloxetine, pregabalin) with limited long-term efficacy.

Fibromyalgia Treatment Protocol

StemCell Longevita's fibromyalgia programme delivers IV WJ-MSC infusion combined with intrathecal delivery to maximise access to central nervous system pain-processing circuits. Pre-treatment evaluation includes tender point count, FIQ assessment, inflammatory panel, and exclusion of secondary causes. The 5–7 day Istanbul programme includes post-treatment pain management guidance and 12-month telemedicine follow-up with validated outcome measurement at each visit.

Frequently Asked Questions

How does stem cell therapy help chronic pain?

MSCs address the root cause of chronic pain by reducing inflammation, repairing damaged tissues, and modulating pain signaling pathways. Unlike pain medications, MSC therapy targets the underlying condition rather than masking symptoms.

What types of chronic pain can stem cells treat?

We treat chronic back pain, neuropathic pain, fibromyalgia-related pain, joint pain, musculoskeletal pain, and post-surgical chronic pain. Each protocol is customized based on the pain source and mechanism.

How long does pain relief last after stem cell therapy?

Most patients experience significant pain reduction lasting 12-18 months or longer. Many patients report sustained improvement, especially when the underlying tissue damage is repaired by the MSCs.

Is stem cell therapy better than pain medication for chronic pain?

MSC therapy offers a disease-modifying approach that addresses root causes, unlike medications that primarily manage symptoms. Many patients reduce or eliminate their pain medication requirements after MSC treatment.

Related articles: Stem Cell Therapy for Autoimmune Diseases (2026 Research) | Understanding Stem Cell Therapy (2026 Complete Guide) | Is Stem Cell Therapy Safe? Understanding Risks, Benefits & Evidence

Related treatments: Chronic Pain Stem Cell Therapy | Autoimmune Disease Stem Cell Therapy | Lyme Disease Stem Cell Therapy